NASDAQ
12.05.26 | 21:54
0,238 US-Dollar
-0,75 % -0,002
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | IceCure Medical GAAP EPS of $0.06, revenue of $911M | 3 | Seeking Alpha | ||
| Di | IceCure Medical Ltd Q1 Sales Increase | 1 | RTTNews | ||
| Di | IceCure Medical: IceCure Reports First Quarter 2026 Financial Results: ProSense Sales Increase Substantially in the U.S. and North America | 119 | PR Newswire | Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as of the end of the first quarter 2026, compared... ► Artikel lesen | |
| So | Quant snapshot: Beachbody, Deutsche Telekom among top-rated names as IceCure Medical, Fold Holdings lag | 30 | Seeking Alpha | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 06.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 21.04. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 01.04. | IceCure Medical Ltd. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 26.03. | IceCure prices $4M direct offering, concurrent private placement | 2 | Seeking Alpha | ||
| 25.03. | IceCure Medical Reports Positive Trial Results For ProSense Cryoablation System | 2 | RTTNews | ||
| 24.03. | IceCure Medical: IceCure Appoints Meir Peleg as Chief Financial Officer | 185 | PR Newswire | Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companiesIceCure intends to appoint Dr. Richard Fine as Medical Director CAESAREA, Israel... ► Artikel lesen | |
| 24.03. | IceCure Medical Appoints Meir Peleg As CFO; Shares Rise In Pre-market | - | RTTNews | ||
| 24.03. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.03. | IceCure Medical: IceCure Reports 2025 Full Year Financial & Operational Results | 369 | PR Newswire | Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectively
Strong commercial momentum for ProSense® in the U.S. and globally following... ► Artikel lesen | |
| 17.03. | IceCure Medical Ltd Profit Drops In Full Year | - | RTTNews | ||
| 17.03. | IceCure Medical GAAP EPS of -$0.24, revenue of $3.38M | 2 | Seeking Alpha | ||
| 17.03. | IceCure Medical Ltd. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 11.03. | IceCure Medical: U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense Cryoablation in the Local Treatment of Low-Risk Breast Cancer | 394 | PR Newswire | IceCure is engaged with leading medical institutions throughout the U.S. looking to participate in the post-market study with the FDA-cleared ProSense®
Clinical... ► Artikel lesen | |
| 11.03. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 02.03. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 02.03. | IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas | 246 | PR Newswire | Treatment with ProSense® resulted in 92.9% volume reduction of fibroadenoma one-year post-cryoablation
Findings may impact treatment guidelines issued by medical... ► Artikel lesen |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 5,190 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic | HOUSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ORGANON | 11,315 | 0,00 % | Organon & Co.: Europäische Kommission erteilt Marktzulassung für POHERDY (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,720 | 0,00 % | Co-Diagnostics JV secures KSA facility lease deal; CODX rallies 16% premarket | ||
| SENSEONICS | 4,680 | -4,49 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| VIRIDIAN THERAPEUTICS | 14,400 | -2,04 % | XFRA 1S1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILVIRIDIAN THERAPEUTICS... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,800 | +2,72 % | Inspire Medical Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| EMBECTA | 2,902 | +2,15 % | Embecta stock rating held at Neutral by BTIG after investor meetings | ||
| VYOME | 1,990 | +1,02 % | Vyome: Positive Phase-2-Daten für Wundbehandlung bei Krebspatienten | ||
| PROCEPT BIOROBOTICS | 28,730 | +8,62 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 35,760 | +3,26 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 22,800 | +12,43 % | TACTILE SYSTEMS TECHNOLOGY INC - 8-K, Current Report | ||
| APYX MEDICAL | 3,480 | +4,82 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| GLAUKOS | 116,00 | +1,75 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,597 | -1,29 % | Lexaria Bioscience Corp.: Lexaria Bioscience Releases Second Episode of Investor Video Series | CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities KELOWNA, BC / ACCESS Newswire / May 7, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen | |
| ITONIC | 0,304 | -2,38 % | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,002 (-0,75 %) liegt der Kurs bei 0,238 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.